Trial intelligence / Profile preview

Chlorhexidine mouthwash to reduce respiratory tract infections after abdominal surgery

PACTR202211513812190Phase 3Not yet recruiting

Sponsor
Tamale Teaching Hospital
Start
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of chlorhexidine in Airways Infection (2 arms), sponsored by Tamale Teaching Hospital. Primary endpoint: respiratory tract infection. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

chlorhexidine
03

Conditions

Airways Infection

Beyond the preview

Go deeper on PACTR202211513812190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202211513812190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call